Gavin Leech
Overview
Explore the profile of Gavin Leech including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gavenciak T, Teperowski Monrad J, Leech G, Sharma M, Mindermann S, Bhatt S, et al.
PLoS Comput Biol
. 2022 Aug;
18(8):e1010435.
PMID: 36026483
Although seasonal variation has a known influence on the transmission of several respiratory viral infections, its role in SARS-CoV-2 transmission remains unclear. While there is a sizable and growing literature...
2.
Leech G, Rogers-Smith C, Teperowski Monrad J, Sandbrink J, Snodin B, Zinkov R, et al.
Proc Natl Acad Sci U S A
. 2022 May;
119(23):e2119266119.
PMID: 35639701
The effectiveness of mask wearing at controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been unclear. While masks are known to substantially reduce disease transmission in healthcare settings...
3.
Altman G, Ahuja J, Teperowski Monrad J, Dhaliwal G, Rogers-Smith C, Leech G, et al.
Sci Data
. 2022 Apr;
9(1):145.
PMID: 35365668
During the second half of 2020, many European governments responded to the resurging transmission of SARS-CoV-2 with wide-ranging non-pharmaceutical interventions (NPIs). These efforts were often highly targeted at the regional...
4.
Sharma M, Mindermann S, Rogers-Smith C, Leech G, Snodin B, Ahuja J, et al.
Nat Commun
. 2021 Oct;
12(1):5820.
PMID: 34611158
European governments use non-pharmaceutical interventions (NPIs) to control resurging waves of COVID-19. However, they only have outdated estimates for how effective individual NPIs were in the first wave. We estimate...
5.
Mishra S, Mindermann S, Sharma M, Whittaker C, Mellan T, Wilton T, et al.
EClinicalMedicine
. 2021 Aug;
39:101064.
PMID: 34401689
Background: Since its emergence in Autumn 2020, the SARS-CoV-2 Variant of Concern (VOC) B.1.1.7 (WHO label Alpha) rapidly became the dominant lineage across much of Europe. Simultaneously, several other VOCs...
6.
Brauner J, Mindermann S, Sharma M, Johnston D, Salvatier J, Gavenciak T, et al.
Science
. 2020 Dec;
371(6531).
PMID: 33323424
Governments are attempting to control the COVID-19 pandemic with nonpharmaceutical interventions (NPIs). However, the effectiveness of different NPIs at reducing transmission is poorly understood. We gathered chronological data on the...